CORPAY CEO and Chairman Ronald Clarke sold 5,882 shares on 2026-08-24 at $414.16 per share, a transaction worth about $2.44 million. Because this is a sale (not a purchase), it’s typically a weaker indicator of insider conviction—executives sell for many reasons unrelated to the business, such as taxes, diversification, or personal liquidity. The filing details provided don’t indicate whether the trade was made under a pre-arranged 10b5-1 plan, which would generally make it more routine. Clarke’s roles as both CEO and board chair matter because he is among the people with the broadest view of company performance, strategy, and risks. Investors often pay closer attention to trades by top executives than by lower-level insiders, especially when they occur near other insider transactions. This sale also fits into a notable cluster of insider selling over the past month at CPAY. In the last 30 days, multiple insiders reported sales, including Alan King ($3.41M on 2026-08-20 and $1.59M on 2026-08-21) and Steven T. Stull ($186.64K on 2026-08-18, $362.95K on 2026-08-20). A pattern of several insiders selling around the same time can signal coordinated liquidity or planned selling programs, but without plan disclosures and the insiders’ remaining holdings, it’s hard to judge how significant the selling is relative to their overall stakes.